Kyverna ‘resetting conversation’ with 1-year miv-cel data as autoimmune CAR-T peers hit safety snags Read more →
Lilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCare Read more →
Enveda reaps $311M series E to feed ambition to become a ‘household name’ Read more →
« All Events
February 5, 2025 @ 8:30 am
The agenda at BioInfect will focus on the issues surrounding the increasing threat of AMR and how it can be addressed.